4,145 Shares in Marsh & McLennan Companies, Inc. $MRSH Bought by Connecticut Wealth Management LLC

Connecticut Wealth Management LLC acquired a new position in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 4,145 shares of the financial services provider’s stock, valued at approximately $769,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of MRSH. Numerai GP LLC boosted its position in Marsh & McLennan Companies by 966.2% during the third quarter. Numerai GP LLC now owns 37,220 shares of the financial services provider’s stock worth $7,501,000 after purchasing an additional 33,729 shares in the last quarter. Swiss Life Asset Management Ltd boosted its position in Marsh & McLennan Companies by 9.5% during the fourth quarter. Swiss Life Asset Management Ltd now owns 134,542 shares of the financial services provider’s stock worth $24,960,000 after purchasing an additional 11,648 shares in the last quarter. Barclays PLC boosted its position in Marsh & McLennan Companies by 41.7% during the third quarter. Barclays PLC now owns 2,202,372 shares of the financial services provider’s stock worth $443,844,000 after purchasing an additional 647,987 shares in the last quarter. Sarasin & Partners LLP boosted its position in Marsh & McLennan Companies by 0.9% during the fourth quarter. Sarasin & Partners LLP now owns 934,732 shares of the financial services provider’s stock worth $173,411,000 after purchasing an additional 8,283 shares in the last quarter. Finally, Brown Brothers Harriman & Co. boosted its position in Marsh & McLennan Companies by 26.4% during the third quarter. Brown Brothers Harriman & Co. now owns 136,179 shares of the financial services provider’s stock worth $27,444,000 after purchasing an additional 28,419 shares in the last quarter. Institutional investors and hedge funds own 87.99% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have commented on MRSH. Raymond James Financial upgraded Marsh & McLennan Companies from an “outperform” rating to a “strong-buy” rating and set a $225.00 target price on the stock in a research report on Tuesday, February 17th. Barclays reduced their price objective on Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 8th. Piper Sandler reduced their price objective on Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 26th. JPMorgan Chase & Co. reduced their price objective on Marsh & McLennan Companies from $226.00 to $206.00 and set an “overweight” rating on the stock in a research report on Thursday, April 9th. Finally, UBS Group reduced their price objective on Marsh & McLennan Companies from $230.00 to $203.00 and set a “buy” rating on the stock in a research report on Tuesday. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, ten have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Marsh & McLennan Companies presently has an average rating of “Hold” and a consensus price target of $200.19.

Marsh & McLennan Companies Trading Up 0.6%

NYSE MRSH opened at $168.20 on Friday. Marsh & McLennan Companies, Inc. has a twelve month low of $156.60 and a twelve month high of $220.32. The stock has a market cap of $81.26 billion, a P/E ratio of 21.02, a price-to-earnings-growth ratio of 2.43 and a beta of 0.62. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 1.28.

Marsh & McLennan Companies (NYSE:MRSH) last released its earnings results on Thursday, April 16th. The financial services provider reported $3.29 earnings per share for the quarter, topping the consensus estimate of $3.21 by $0.08. The firm had revenue of $7.30 billion for the quarter. Marsh & McLennan Companies had a return on equity of 31.87% and a net margin of 14.26%.The company’s revenue was up 7.6% compared to the same quarter last year. As a group, research analysts anticipate that Marsh & McLennan Companies, Inc. will post 10.38 earnings per share for the current year.

Insider Buying and Selling

In other Marsh & McLennan Companies news, CEO John Q. Doyle sold 16,656 shares of the company’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the completion of the sale, the chief executive officer directly owned 116,811 shares in the company, valued at $18,889,506.81. This represents a 12.48% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.38% of the stock is owned by corporate insiders.

Marsh & McLennan Companies Company Profile

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.